REMUS — Remus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Remus Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	12	8.3	11.5	30.4	293
Net Total Accounts Receivable
Net Total Receivables	31.3	55.2	49.6	80.2	1,375
Total Inventory
Total Current Assets	47.6	75	76.9	113	2,097
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.01	3.92	3.08	25.1	22.8
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	53	110	159	347	2,573
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29.3	76.9	92	81.6	1,495
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	32.8	80	94.8	155	1,704
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	20.2	30.5	64.3	191	869
Total Liabilities & Shareholders' Equity	53	110	159	347	2,573
Total Common Shares Outstanding